1. Merck trashes both of its COVID vaccine candidates due to weak clinical data — Big medtech deals keep on turning — Moderna says its COVID-19 vaccine is less effective against the South African variant — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice

Quick Navigation Menu

Forum List